PerkinElmer, Inc. (United States)
(NYSE : PKI)

( )
PKI After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp. -1.53%321.510.7%$882.54m
TMOThermo Fisher Scientific, Inc. -2.41%633.151.0%$857.83m
ABTAbbott Laboratories -1.89%125.610.8%$662.68m
MDTMedtronic Plc -3.24%106.710.6%$623.96m
ISRGIntuitive Surgical, Inc. -3.11%324.340.8%$451.92m
DXCMDexCom, Inc. -1.48%562.597.8%$377.07m
BDXBecton, Dickinson & Co. -2.68%237.091.0%$363.70m
BSXBoston Scientific Corp. -1.63%37.961.0%$342.68m
ALGNAlign Technology, Inc. -3.62%611.536.4%$321.01m
SYKStryker Corp. -2.85%236.561.3%$305.17m
EWEdwards Lifesciences Corp. -3.13%107.240.4%$256.34m
AAgilent Technologies, Inc. -1.65%150.891.6%$245.52m
IDXXIDEXX Laboratories, Inc. -3.68%608.073.8%$230.32m
ZBHZimmer Biomet Holdings, Inc. -3.17%119.591.7%$221.27m
WSTWest Pharmaceutical Services, Inc. -1.01%442.861.6%$189.13m

Company Profile

PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.